Nephros(NEPH)

TOPVIEW |2021.7.8 Bio-market主要涨跌一览

蹊之美股生物医药2021-07-09 20:55

作者：林出
微信公众号：蹊之美股生物医药 / CaesarBiotech
Gainers: 
Aerpio Pharm (ARPO) +63.16%
GBS Inc (GBS) +33.22%
Alterity Therapeutics (ATHE) +27.85%
9 Meters Biopharma (NMTR) +20.39%
F-star Therapeutics (FSTX) +9.13%
Los...查看全文

其他

$Nephros(NEPH)$ DEFA14A Additional definitive proxy soliciting materials and Rule 14(a)(12) material Accession Number: 0001493152-24-014447  Act: 34  Size: 709 KB 网页链接

其他

$Nephros(NEPH)$ ARS Annual Report to Security Holders Accession Number: 0001493152-24-014448  Act: 34  Size: 1 MB 网页链接

股东委托书协议

$Nephros(NEPH)$ DEF 14A Other definitive proxy statements Accession Number: 0001493152-24-014442  Act: 34  Size: 1 MB 网页链接

年度财报

$Nephros(NEPH)$ 10-K Annual report [Section 13 and 15(d), not S-K Item 405] Accession Number: 0001493152-24-010107  Act: 34  Size: 7 MB 网页链接

持股变动声明

$Nephros(NEPH)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001048462-24-000012  Size: 12 KB 网页链接

持股变动声明

$Nephros(NEPH)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001048462-24-000011  Size: 6 KB 网页链接

当期报告

$Nephros(NEPH)$ 8-K Current report, items 2.02 and 9.01 Accession Number: 0001493152-24-009216  Act: 34  Size: 345 KB 网页链接

持股变动声明

$Nephros(NEPH)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001062993-23-022642  Size: 4 KB 网页链接

持股变动声明

$Nephros(NEPH)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001062993-23-022644  Size: 11 KB 网页链接

持股变动声明

$Nephros(NEPH)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001062993-23-022643  Size: 7 KB 网页链接